HENRY SCHEIN INC

HSIC Healthcare
$73.94
Market Cap $8.70B
P/E Ratio 22.61
Forward P/E 12.60
Dividend Yield —
Beta 0.88
52W Range $62.03 - $83.35
# Hedge Funds 5
Sector Healthcare
Industry Medical Distribution

Hedge Fund Ownership

4 funds holding this stock
Investor 4 % of Portfolio i Weight of this stock in the investor's portfolio Value i Total dollar value of the position Shares i Number of shares held Activity i Portfolio change type: New, Increased, Decreased, or Sold
Robert Olstein Olstein Capital Management 1.38% $6.00K 89,000 Reduce 11.00%
David Einhorn DME Capital Management 1.24% $35.47M 469,250 Buy
Richard Pzena Pzena Investment Management 0.20% $67.09M 887,725 Reduce 4.13%
Mason Hawkins Southeastern Asset Management 0.06% $1.29M 17,038 Reduce 18.72%

Insider Trading

13 transactions in the last 6 months
Insider i Name of the company insider who made the trade 13 Type i Purchase (buy) or Sale (sell) Shares i Number of shares traded Price i Price per share at time of transaction Value i Total dollar value of the transaction Trade Date i Date the transaction was executed Filing Date i Date the SEC filing was submitted
Popeck Thomas CCEO, Henry Schein ProductsSale1,355$72.79$98.63K19 Mar 202619 Mar 2026
KUEHN KURT PSale2,844$78.96$224.57K10 Mar 202610 Mar 2026
LASKAWY PHILIP ASale2,844$80.36$228.54K05 Mar 202606 Mar 2026
Philip A LaskawyDirectorSale2,844$80.36$228.54K05 Mar 202606 Mar 2026
MLOTEK MARK EEVP, Chief Strategic OfficerSale4,100$80.80$331.26K04 Mar 202606 Mar 2026
MLOTEK MARK EEVP, Chief Strategic OfficerSale1,825$80.81$147.48K04 Mar 202606 Mar 2026
Mark E MlotekEVP, Chief Strategic OfficerSale4,100$80.80$331.26K04 Mar 202606 Mar 2026
Mark E MlotekEVP, Chief Strategic OfficerSale1,825$80.81$147.48K04 Mar 202606 Mar 2026
BERGMAN STANLEY MChairman, CEOSale19,954$81.31$1.62M02 Mar 202603 Mar 2026
BERGMAN STANLEY MChairman, CEOSale23,858$81.31$1.94M02 Mar 202603 Mar 2026
BERGMAN STANLEY MChairman, CEOSale10,785$81.20$875.74K27 Feb 202627 Feb 2026
BERGMAN STANLEY MChairman, CEOSale31,134$80.90$2.52M26 Feb 202627 Feb 2026
BERGMAN STANLEY MChairman, CEOSale7,212$81.51$587.85K26 Feb 202627 Feb 2026

Frequently Asked Questions

What is HSIC stock price today?

HENRY SCHEIN INC (HSIC) is currently trading at $73.94. The stock has a 52-week range of $62.03 to $83.35 and a market capitalization of $8.70B.

Is HSIC a good stock to buy in 2026?

HENRY SCHEIN INC has a P/E ratio of 22.6 (forward P/E: 12.6), a dividend yield of none, and 1-year performance of +11.0%. 4 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.

Are insiders buying or selling HSIC stock?

There have been 13 insider transactions for HSIC in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.

How has HSIC stock performed over the past year?

HENRY SCHEIN INC (HSIC) has returned +11.0% over the past 12 months. The stock traded between $62.03 and $83.35 during this period, and is currently at $73.94.

Which hedge funds own HSIC (HENRY SCHEIN INC)?

4 tracked hedge funds currently hold HSIC in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.

What is HSIC's market cap and valuation?

HENRY SCHEIN INC (HSIC) has a market capitalization of $8.70B. The trailing P/E ratio is 22.6 and forward P/E is 12.6. The stock is classified in the Healthcare sector.

What is HSIC's revenue and profitability?

HENRY SCHEIN INC reported revenue of $13.18B with net income of $398.00M and a profit margin of 0.03%. The stock has a beta of 0.88.

What sector is HSIC in and who are its biggest institutional holders?

HENRY SCHEIN INC (HSIC) operates in the Healthcare sector. It is held by 4 tracked hedge funds. See the ownership table above for the complete list.